| News | Events |
| Publications | Companies |
| Clinical Trials |
Monthly Archives: October 2008
-
-
Silence Therapeutics announces Directors share purchases
0 Replies
-
Press Release – Calando Pharmaceuticals Announces Completion of IT-101 Phase 1 Clinical Study.
0 Replies
-
Silence Therapeutics announces Directors share purchases
0 Replies
-
Silence Therapeutics announces Directors share purchases
0 Replies
-
AGM Statement 2008
0 Replies
-
New class of drug candidates developed by Santaris Pharma can potently counteract disease-associated microRNAs
0 Replies
-
Santaris Pharmas microRNA lægemiddelkandidater hæmmer effektivt sygdomsrelaterede microRNA’er
0 Replies